參考文獻(xiàn)/References:
[1] McCune W S,Shorb P E,Moscovitz H.Endoscopic cannulation of the ampulla of vater[J].Annals of Surgery,1968,167(5):752-755.
[2] Testoni P A, Mariani A, Aabakken L, et al.Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy(ESGE)Clinical Guideline[J].Endoscopy,2016,48(7):657.
[3] van Westerloo D J, Rauws E A, Hommes D, et al.Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence[J].Gastrointestinal Endoscopy,2008,68(2):246-254.
[4] Cotton P B, Lehman G, Vennes J, et al.Endoscopic sphincterotomy complications and their management: an attempt at consensus[J].Gastrointestinal Endoscopy,1991,37(3):383.
[5] Bourke M J, Ma M X.14-Cannulation of the Major Papilla[M].3rd ed.Philadelphia:Elsevier,2019:108-122.
[6] Andriulli A, Loperfido S,Napolitano G,et al.Incidence rates of post-ERCP complications: a systematic survey of prospective studies[J].Am J Gastroenterol, 2007, 102(8): 1781-1788.
[7] Nakai Y, Isayama H, Sasahira N, et al.Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP[J].Gastrointestinal Endoscopy,2015,81(1):119-126.